Skip to main content
CING logo

Cingulate Inc.

CINGNASDAQHealthcareBiotechnology

$4.69Today:- (-)1Y +31.01%

As of Oct 22, 2026 close

Market cap
$61.84M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.16$11.89
Volume (live)
-
Avg. volume (3M)
96.82K

Cingulate (CING) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Cingulate reported total assets of $15.07M and total liabilities of $12.56M. Shareholders' equity was $2.51M, down 66.3% from $7.46M a year earlier. Total debt stood at $7.45M against $10.95M in cash and short-term investments, a net cash position of $3.51M. That puts debt-to-equity at 2.97, compared with 0.67 a year earlier.

Cingulate Balance Sheet Analysis

Values in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cingulate Inc. (CING) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents0.010.010.000.000.010.020.000.00
Short-Term Investments0.000.000.00-0.000.000.000.00
Cash & Short-Term Investments0.010.010.000.000.010.020.000.00
Accounts Receivable0.000.000.000.000.000.000.000.00
Inventory0.000.000.00-0.000.000.000.00
Other Current Assets0.000.000.000.000.000.000.000.00
Total Current Assets0.010.010.000.000.010.020.000.00
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.000.000.00
Other Non-Current Assets0.000.000.00--5.910.000.000.00
Total Non-Current Assets0.000.000.000.000.000.000.000.00
Total Assets0.020.010.000.000.010.020.010.01
Current Liabilities
Accounts Payable0.000.000.010.010.000.000.000.00
Short-Term Debt0.010.000.000.000.010.000.000.00
Current Portion of Long-Term Debt-0.00------
Accrued Liabilities0.000.00-0.000.000.000.00-
Deferred Revenue0.000.000.00-0.000.000.000.00
Other Current Liabilities0.000.000.000.000.000.000.000.00
Total Current Liabilities0.010.000.010.010.010.000.000.00
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.000.000.000.00
Other Non-Current Liabilities0.000.000.00-0.000.000.000.00
Total Non-Current Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities0.010.010.010.010.010.000.000.00
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.030.00
Retained Earnings-0.13-0.11-0.09-0.09-0.07-0.05-0.030.00
Accumulated Other Comprehensive Income0.000.000.00-0.000.000.000.00
Additional Paid-in Capital0.130.120.090.090.070.070.000.00
Shares Outstanding0.010.00-0.000.000.00--
Total Stockholders' Equity0.000.01-0.01-0.010.000.020.000.00
Total Liabilities & Equity0.020.010.000.000.010.020.010.01

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cingulate Balance Sheet

How much debt does Cingulate have?

Cingulate had total debt of $7.45M as of Dec 31, 2025, against $10.95M in cash and short-term investments. Its debt-to-equity ratio was 2.97. Total debt was $4.96M a year earlier.

What are Cingulate's total assets?

Cingulate reported total assets of $15.07M as of Dec 31, 2025, up 1.4% from $14.86M a year earlier. Total liabilities were $12.56M.

What is Cingulate's shareholders' equity?

Cingulate's shareholders' equity was $2.51M as of Dec 31, 2025, or about $0.35 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition